600521 Stock Overview
Operates as a pharmaceutical company in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Zhejiang Huahai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥17.05 |
| 52 Week High | CN¥19.09 |
| 52 Week Low | CN¥10.71 |
| Beta | 0.085 |
| 11 Month Change | -1.67% |
| 3 Month Change | 30.05% |
| 1 Year Change | -6.93% |
| 33 Year Change | -18.11% |
| 5 Year Change | 22.34% |
| Change since IPO | 90.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600521 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -3.8% | -3.7% | -2.2% |
| 1Y | -6.9% | -17.3% | -17.9% |
Return vs Industry: 600521 exceeded the CN Pharmaceuticals industry which returned -17.3% over the past year.
Return vs Market: 600521 exceeded the CN Market which returned -17.9% over the past year.
Price Volatility
| 600521 volatility | |
|---|---|
| 600521 Average Weekly Movement | 4.7% |
| Pharmaceuticals Industry Average Movement | 5.6% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.1% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 600521's share price has been volatile over the past 3 months.
Volatility Over Time: 600521's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 8,221 | Bao Hua Chen | www.huahaipharm.com |
Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as high-density polyethylene bottles and polypropylene caps for pharmaceuticals.
Zhejiang Huahai Pharmaceutical Co., Ltd. Fundamentals Summary
| 600521 fundamental statistics | |
|---|---|
| Market cap | CN¥24.71b |
| Earnings (TTM) | CN¥928.37m |
| Revenue (TTM) | CN¥8.75b |
26.7x
P/E Ratio2.8x
P/S RatioIs 600521 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600521 income statement (TTM) | |
|---|---|
| Revenue | CN¥8.75b |
| Cost of Revenue | CN¥3.54b |
| Gross Profit | CN¥5.21b |
| Other Expenses | CN¥4.28b |
| Earnings | CN¥928.37m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 59.59% |
| Net Profit Margin | 10.61% |
| Debt/Equity Ratio | 96.2% |
How did 600521 perform over the long term?
See historical performance and comparison